Business Wire

Agendia Appoints Farida Peters-Abbadi as Vice President of Marketing

Share

Agendia, Inc., a commercial stage company focused on enabling optimized decision-making by providing physicians with next-generation diagnostic and information solutions that can be used to help improve outcomes for breast cancer patients worldwide, today announced the appointment of seasoned diagnostic and medical device executive Farida Peters-Abbadi as Vice President of Marketing, effective April 4, 2022.

“Farida is an exciting addition to our executive team as we focus on accelerating commercial growth and introducing new groundbreaking products and services for breast cancer patients and their physicians,” said Betsy Hanna, Executive Vice President and Chief Commercial Officer at Agendia. “Not only has she consistently driven commercial growth and structural evolution in other pioneering diagnostic and device companies, she’s done so with a dynamism that we feel is requisite for success at and for Agendia. Her experience, specifically in establishing women’s health companies and launching first-to-market products, will help our teams accelerate the achievement of Agendia’s goals in the near future.”

Most recently, Ms. Peters-Abbadi served as President and Chief Commercial Officer at Mirvie, an early-stage liquid biopsy diagnostic company, where she led the commercial, regulatory, and clinical strategy, developed the go-to-market and launch plans, and secured funding for a capital raise. Prior to that, she held a P&L leadership role as Vice President of Sales and Marketing at Renovia, an early-stage medical device company, where she was responsible for healthcare provider marketing, direct-to-consumer marketing, sales and customer service, partnerships, and commercial operations, ultimately delivering 80% year-over-year revenue growth.

Ms. Peters-Abbadi also held a series of sales and sales management roles at ViaCell before joining PerkinElmer, where over the course of 12 years she rose to the level of Director of Marketing and led the launch plans for non-invasive prenatal testing that achieved a 25% increase in revenue. Her education includes double law degrees from McGill University, an Executive Master of Business Administration from Northwestern University’s Kellogg School of Management and a Bachelor of Arts from Binghamton University.

“My passion for women’s health is rooted in the conviction that women deserve effective solutions that prioritize their quality of life. My aim is to integrate my expertise as a marketing strategist into the robust efforts already underway at Agendia,” said Ms. Peters-Abbadi. “The combination of established products like MammaPrint and BluePrint, and a pipeline of products with the potential to transform the standard of care and impact the lives of more patients worldwide, makes for a natural fit. I look forward to bringing innovation to Agendia’s ongoing positive commercial momentum and accelerating its success.”

Ms. Peters-Abbadi’s appointment comes as the Agendia Board and management team adds to the strong executive and operational talent in the company at all levels. The company believes this dedication translates into exceptional science, actionable and transformative research, and bringing innovative new products to market to ensure patients with breast cancer, their families, and their physicians have access to the information they need to make the best decisions about the treatment journey.

About Agendia

Agendia is a mission-driven, commercial stage company focused on enabling optimized decision-making by providing physicians with next-generation diagnostic and information solutions that can be used to help improve outcomes for breast cancer patients worldwide. The company currently offers two commercially-available genomic profiling tests that help surgeons, oncologists and pathologists to personalize treatment for women at critical intervention points throughout their patient journey.

MammaPrint® is a 70-gene prognostic test that, along with other clinicopathologic factors, determines a specific patient’s breast cancer recurrence risk. BluePrint® is an 80-gene molecular subtyping test that identifies the underlying biology of an individual breast cancer to provide information about its behavior, long-term prognosis and potential response to systemic therapy. Together, MammaPrint® and BluePrint® provide a holistic view of an individual patient’s breast cancer, enabling physicians to objectively select the best treatment plan.

For more information on Agendia’s assays and ongoing trials, please visit www.agendia.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media

Terri Clevenger
ICR Westwicke Healthcare PR
Tel: 203.856.4326
Terri.Clevenger@icrinc.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Fabasoft Approve is now an autonomous limited liability company23.5.2022 17:05:00 EEST | Press release

Fabasoft Approve, the product for managing technical data and documents launched by software manufacturer Fabasoft and employed successfully in industry since 2019, became an independent company on April 27, 2022. Entrepreneur Andreas Dangl will assume the management of the new digitalization services company. As a defining leader in the Fabasoft Group, Dangl was responsible for the development of Fabasoft Cloud technology and was both the idea generator as well as the principal architect of software products including Fabasoft Approve. He is now pooling his expertise in the corporation based in Linz (Austria) with the express intention of re-imagining the digital world in mechanical and plant engineering and rendering it simpler to navigate. “Fabasoft Approve GmbH provides the perfect framework for meeting the needs of our industrial customers in an even more focused way. We have exciting times ahead of us, in which my team and I, together with our clients, will tap the innovative pot

“PUMA and the Land of Games”: New Virtual Place on Roblox for PUMA Fans to Connect and Compete23.5.2022 17:00:00 EEST | Press release

PUMA in partnership with Wonder Works studio launches a vibrant and immersive sports-based experience on Roblox, a global online platform connecting millions of people through shared experiences. PUMA and the Land of Games experience features Roblox newest Layered Clothing technology, where players can customize their characters with hyperrealistic clothing that fits any avatar body type to wear PUMA from head to toe. As they explore the experience, fans will unlock new zones and additional PUMA sportswear pieces. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220523005611/en/ PUMA in partnership with Wonder Works studio launches a vibrant and immersive sports-based experience on Roblox, a global online platform connecting millions of people through shared experiences. (Photo: Business Wire) “PUMA and the Land of Games” offers the global Roblox community to bring out their inner athlete through sports mini games and training

Fabrice Tocco, Dawex co-CEO, Speaking at the World Economic Forum Annual Meeting in Davos about Data Ecosystems to Respond to Competitiveness and Economic Sovereignty Challenges23.5.2022 16:40:00 EEST | Press release

Dawex, the leading technology company for data exchange, data marketplace and data hub, announced today that co-CEO Fabrice Tocco will be speaking at the World Economic Forum Annual Meeting in Davos, and will share his vision on creating new data exchange ecosystems to respond to environmental and economic challenges. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220523005654/en/ Live Session at Davos (Photo: Dawex) “Strengthening Trust in Public-Private Data Exchanges” Tuesday, May 24 at 13:30 CET Data ecosystems have become a fundamental component of business competitiveness and economic sovereignty. In today’s economy where data has become a product of unlimited potential, with its own value, and a source of new revenue streams, Dawex technology allows organizations to create new ecosystems around data exchange platforms that meet regulatory requirements and address traceability and security challenges. About Dawex In to

Daiichi Sankyo Europe highlights need to address the perception and classification of CVD risk with data presentations at EAS 202223.5.2022 16:15:00 EEST | Press release

Daiichi Sankyo Europe, (hereafter, Daiichi Sankyo) announced today multiple data presentations at the European Atherosclerosis Society (EAS) Congress 2022, highlighting the need to address current clinical perceptions and classification of risk of developing or exacerbating cardiovascular disease (CVD).1,2 Latest data from SANTORINI, a multinational, prospective, observational study designed to assess the management of high- and very high-risk CV patients requiring lipid-lowering therapy (LLT) in routine clinical practice, demonstrated that the CV risk of patients analysed was notably underestimated in clinical practice according to European guidelines.1,2,3 Data show that of the 9,044 patients analysed within the SANTORINI study 70.8% of patients were classified by the investigators as being at very high-risk and 29.2% as high-risk of heart attack or stroke. However, of those high-risk patients, 41.5% demonstrated evidence of atherosclerotic cardiovascular disease (ASCVD) which dictat

Coliseo De Puerto Rico and ASM Global Recognize 10,000,000th Visitor at Tommy Torres Concert23.5.2022 16:00:00 EEST | Press release

The Coliseo de Puerto Rico José Miguel Agrelot and ASM Global, the world’s largest producer of live entertainment experiences, surprised Melanie Biringer-Figueroa with the news of being the 10,000,000th visitor to the “Choli” as she made her entrance to the venue on Saturday to enjoy the Tommy Torres concert, “El Playlist de Anoche Live.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220523005410/en/ ASM Global’s Coliseo de Puerto Rico Jose Miguel Agrelot’s Jorge L. Pérez, CVE, regional manager of ASM Global, (center) and Mariela Vallines, executive director of the Puerto Rico Convention District Authority, (left) celebrate with fan Melanie Biringer-Figueroa (right) with news of Biringer-Figueroa being the revered venue’s 10,000 000th visitor this weekend. (Photo courtesy ASM Global). “We are overjoyed to be able to recognize our 10 millionth visitor and celebrate this historic and special moment with her,” said Jorge L. Pé

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom